The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
ViraCyte has been awarded $3.75M from NIH and the FDA to advance its T cell immunotherapies.
read more
Alnylam Pharmaceuticals and Sanofi Genzyme announced the initiation of the ATLAS Phase 3 clinical program for fitusiran.
read more
Bristol-Myers Squibb announced the FDA has approved ORENCIA for the treatment of adults with active PsA.
read more
Boston Biomedical announced the FDA has granted ODD for DSP-7888, an investigational cancer peptide vaccine, for the treatment of MDS.
read more
Emmaus Life Sciences announced the FDA approved Endari to reduce the severe complications of sickle cell disease in adult and pediatric patients age 5...
read more
Dermavant Sciences announced the appointment of Dr. Jacqualyn "Jackie" Fouse as Executive Chairman.
read more
Eli Lilly announced the FDA has accepted and filed its NDA for abemaciclib, a cyclin-dependent kinase (CDK)4 & 6 inhibitor, and given the NDA a ...
read more
Arena Pharmaceuticals announced positive Phase 2 results for ralinepag, an investigational, long-acting, orally administered prostacyclin receptor ...
read more
Regen BioPharma reported continued progress in developing small molecule drugs that activate and inhibit NR2F6.
read more
Biohaven received a Notice of Allowance from the USPTO for its patent application number 14/385551, which covers prodrugs of the glutamate modulating ...
read more
Novartis announced the FDA unanimously recommended approval of CTL019 for the treatment of relapsed or refractory pediatric and young adult patients ...
read more
Amgen announced positive results from the final analysis of the Phase 3 ASPIRE trial for KYPROLIS, lenalidomide and dexamethasone.
read more
MMRF has contracted Avista Pharma to manufacture an opioid-derived small molecule, a key component of a conjugate vaccine in development to treat ...
read more
CTI BioPharma announced that EMA has validated the MAA for pacritinib for the treatment of patients with myelofibrosis who have thrombocytopenia.
read more
Sangamo Therapeutics announced the FDA granted Fast Track designation to SB-318 and SB-913.
read more